Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Magnesium for Pediatric Asthma (IMPACT-ED)
NCT05166811Phase 2Completed
- Sponsor
- University of Utah
- Start
- Sep 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of magnesium sulfate in asthma, sponsored by University of Utah. Primary endpoint: Enrollment Feasibility at 7 months. Started Sep 2022; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05166811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05166811.